119 related articles for article (PubMed ID: 23339086)
1. SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
Zinzani PL; Marchetti M; Billio A; Barosi G; Carella AM; Lazzarino M; Martelli M; Rambaldi A; Rigacci L; Tarella C; Vitolo U; Tura S;
Am J Hematol; 2013 Mar; 88(3):185-92. PubMed ID: 23339086
[TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma: emerging therapeutic strategies.
Kenkre VP; Kahl BS
Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
[TBL] [Abstract][Full Text] [Related]
3. Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.
Bachy E; Salles G
Best Pract Res Clin Haematol; 2011 Jun; 24(2):257-70. PubMed ID: 21658622
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategies in advanced stage follicular lymphoma.
van Oers MH; Kersten MJ
Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618
[TBL] [Abstract][Full Text] [Related]
5. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
[TBL] [Abstract][Full Text] [Related]
6. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R
Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
[TBL] [Abstract][Full Text] [Related]
7. Rituximab maintenance therapy for follicular lymphoma: no better than watchful waiting.
Prescrire Int; 2012 Mar; 21(125):62. PubMed ID: 22428182
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in autologous stem cell transplantation for follicular lymphoma.
Schmitz N
Anticancer Drugs; 2001 Jun; 12 Suppl 2():S21-4. PubMed ID: 11508933
[TBL] [Abstract][Full Text] [Related]
9. Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.
Lazzarino M; Arcaini L; Orlandi E; Iacona I; Bernasconi P; Calatroni S; Varettoni M; Isa L; Brusamolino E; Bonfichi M; Passamonti F; Burcheri S; Pascutto C; Regazzi M
Oncology; 2005; 68(2-3):146-53. PubMed ID: 16006752
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: a multicenter phase II study.
Tobinai K; Igarashi T; Itoh K; Kurosawa M; Nagai H; Hiraoka A; Kinoshita T; Uike N; Ogura M; Nawano S; Mori S; Ohashi Y;
Cancer Sci; 2011 Sep; 102(9):1698-705. PubMed ID: 21645173
[TBL] [Abstract][Full Text] [Related]
12. Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Barosi G; Carella A; Lazzarino M; Marchetti M; Martelli M; Rambaldi A; Tarella C; Vitolo U; Zinzani PL; Tura S; ; ;
Haematologica; 2006 Jan; 91(1):96-103. PubMed ID: 16434377
[TBL] [Abstract][Full Text] [Related]
13. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
[TBL] [Abstract][Full Text] [Related]
14. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study.
Askeland G
Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446
[No Abstract] [Full Text] [Related]
15. Biology and treatment of follicular lymphoma.
Piccaluga PP; Sapienza MR; Agostinelli C; Sagramoso C; Mannu C; Sabattini E; Zinzani PL; Pileri SA
Expert Rev Hematol; 2009 Oct; 2(5):533-47. PubMed ID: 21083019
[TBL] [Abstract][Full Text] [Related]
16. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
[No Abstract] [Full Text] [Related]
17. Role of hematopoietic stem cell transplant in the management of follicular lymphoma.
Foster M; Gabriel DA; Shea T
Oncologist; 2009 Jul; 14(7):726-38. PubMed ID: 19561292
[TBL] [Abstract][Full Text] [Related]
18. [Recent therapeutic strategy for follicular lymphoma].
Ogura M
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):787-804. PubMed ID: 17506321
[No Abstract] [Full Text] [Related]
19. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.
Hohloch K; Sahlmann CO; Lakhani VJ; Wulf G; Glass B; Hasenkamp J; Meller J; Riggert J; Trümper L; Griesinger F
Ann Hematol; 2011 Nov; 90(11):1307-15. PubMed ID: 21360108
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic advances for indolent lymphomas].
Ogura M
Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]